BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20686401)

  • 1. Multidetector computed tomography follow-up of hypoattenuating small liver lesions in patients with rectal cancer.
    Tan CH; Bhosale PR; Das P; Crane CH; Viswanathan C; Raval B; Eng C; Iyer RB
    Am J Clin Oncol; 2011 Aug; 34(4):411-6. PubMed ID: 20686401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.
    Krakora GA; Coakley FV; Williams G; Yeh BM; Breiman RS; Qayyum A
    Radiology; 2004 Dec; 233(3):667-73. PubMed ID: 15516602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study.
    Ding P; Liska D; Tang P; Shia J; Saltz L; Goodman K; Downey RJ; Nash GM; Temple LK; Paty PB; Guillem JG; Wong WD; Weiser MR
    Ann Surg; 2012 Jul; 256(1):111-6. PubMed ID: 22664562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?
    Ayez N; Alberda WJ; Burger JW; Eggermont AM; Nuyttens JJ; Dwarkasing RS; Willemssen FE; Verhoef C
    Ann Surg Oncol; 2013 Jan; 20(1):155-60. PubMed ID: 22875644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
    Jaffe TA; Neville AM; Bashir MR; Uronis HE; Thacker JM
    Colorectal Dis; 2013 Nov; 15(11):e654-8. PubMed ID: 23910050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer.
    Khalil HI; Patterson SA; Panicek DM
    Radiology; 2005 Jun; 235(3):872-8. PubMed ID: 15833992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor assessment to predict the likelihood of a diagnosis of metastasis for indeterminate hepatic lesions found at computed tomography in patients with rectal cancer.
    Kang KA; Jang KM; Kim SH; Kang TW; Cha DI
    Clin Radiol; 2017 Jun; 72(6):473-481. PubMed ID: 28258741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
    Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
    Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
    Perez RO; Habr-Gama A; Gama-Rodrigues J; Proscurshim I; Julião GP; Lynn P; Ono CR; Campos FG; Silva e Sousa AH; Imperiale AR; Nahas SC; Buchpiguel CA
    Cancer; 2012 Jul; 118(14):3501-11. PubMed ID: 22086847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
    Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
    Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.
    Capirci C; Rubello D; Pasini F; Galeotti F; Bianchini E; Del Favero G; Panzavolta R; Crepaldi G; Rampin L; Facci E; Gava M; Banti E; Marano G
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1461-9. PubMed ID: 19419820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indeterminate Liver Lesions in Patients With Early Stage Rectal Cancer: Can They Be Ignored?
    van den Broek JJ; Kol SQ; Doodeman J; Schreurs WH; van Geel AM
    Pract Radiat Oncol; 2021; 11(6):502-509. PubMed ID: 34273596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
    De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
    Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.